Does NIVOLUMAB Cause Electrolyte imbalance? 104 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 104 reports of Electrolyte imbalance have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.1% of all adverse event reports for NIVOLUMAB.
104
Reports of Electrolyte imbalance with NIVOLUMAB
0.1%
of all NIVOLUMAB reports
21
Deaths
86
Hospitalizations
How Dangerous Is Electrolyte imbalance From NIVOLUMAB?
Of the 104 reports, 21 (20.2%) resulted in death, 86 (82.7%) required hospitalization, and 12 (11.5%) were considered life-threatening.
Is Electrolyte imbalance Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 104 reports have been filed with the FAERS database.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Electrolyte imbalance?
TORSEMIDE (275)
FUROSEMIDE (265)
LENALIDOMIDE (229)
CISPLATIN (216)
OMEPRAZOLE (208)
CARBOPLATIN (200)
RAMIPRIL (199)
CYCLOPHOSPHAMIDE (195)
SPIRONOLACTONE (193)
TACROLIMUS (183)
Which NIVOLUMAB Alternatives Have Lower Electrolyte imbalance Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE